Adjuvant chemotherapy for poor pathologic response after pre-operative chemoradiation in esophageal cancer: infeasible and illogical

MLA

Megan Greally, and Geoffrey Y. Ku. “Adjuvant Chemotherapy for Poor Pathologic Response after Pre-Operative Chemoradiation in Esophageal Cancer: Infeasible and Illogical.” Journal of Thoracic Disease, vol. 11, Sept. 2019, pp. S1855–60. EBSCOhost, https://doi.org/10.21037/jtd.2019.08.116.

APA

Megan Greally, & Geoffrey Y. Ku. (2019). Adjuvant chemotherapy for poor pathologic response after pre-operative chemoradiation in esophageal cancer: infeasible and illogical. Journal of Thoracic Disease, 11, S1855–S1860. https://doi.org/10.21037/jtd.2019.08.116

Chicago

Megan Greally, and Geoffrey Y. Ku. 2019. “Adjuvant Chemotherapy for Poor Pathologic Response after Pre-Operative Chemoradiation in Esophageal Cancer: Infeasible and Illogical.” Journal of Thoracic Disease 11 (September): S1855–60. doi:10.21037/jtd.2019.08.116.